Healthcare Losers: Vermillion (NASDAQ:VRML), IMRIS Inc (NASDAQ:IMRS), Pacific Biosciences of California (NASDAQ:PACB), Zeltiq Aesthetics (NASDAQ:ZLTQ)
Austin life sciences company Vermillion Inc. (NASDAQ:VRML) reported a fourth-quarter loss of $1.8 million on Thursday on revenue of $1.5 million. Vermillion, Inc. (NASDAQ:VRML)’s stock traded at beginning with a price of $3.03 and throughout the trading session climbed at a high of $3.03 and later when day-trade ended the stock finally declined -5.15% to end at $2.76. Vermillion, Inc. (NASDAQ:VRML)’s stock showed weekly performance of -17.61%.
IMRIS Inc (NASDAQ:IMRS) was downgraded by analysts at Paradigm Capital from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday. IMRIS Inc (NASDAQ:IMRS) yesterday closed at $1.72. In its share capital IMRIS Inc (NASDAQ:IMRS) has 52.03million outstanding shares among them 21.99million shares have been floated in market.
Pacific Biosciences of California Inc. (NASDAQ:PACB) is largely focused on the academic research and agriculture biomarkets. But through its partnership with Roche Holding AG (OTC: RHHBY), which it announced in September 2013, it will develop a diagnostic version of its single-molecule, real-time (SMRT) technology system. Pacific Biosciences of California (NASDAQ:PACB)’s stock in last trading day held volume of 770,101.00million shares as compared to its average volume of 938.05K shares. Pacific Biosciences of California (NASDAQ:PACB) shares after opening at $6.67 attained maximum price of $6.67 and then ended up on $6.20 by decreasing -6.97%.
ZELTIQ Aesthetics Inc (NASDAQ:ZLTQ) Director Kevin Oboyle unloaded 15,000 shares of the company’s stock on the open market in a transaction. Zeltiq Aesthetics Inc (NASDAQ:ZLTQ)’s stock on Mar 10, 2014 reported a decrease of -9.30% to the closing price of $16.19. Its fifty two weeks range was $3.20-$24.79. The total market capitalization recorded $602.44million. The overall volume in the last trading session was 880,499.00million shares. In its share capital, Zeltiq Aesthetics Inc (NASDAQ:ZLTQ) has 36.69million outstanding shares.